{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T13:01:54Z","timestamp":1649163714683},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1007\/s11916-003-0078-1","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T07:59:42Z","timestamp":1180857582000},"page":"229-234","source":"Crossref","is-referenced-by-count":2,"title":["Is there a role for botulinum toxin in the treatment of migraine?"],"prefix":"10.1007","volume":"7","author":[{"given":"Stefan","family":"Evers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"78_CR1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1468-2982.2000.00117.x","volume":"20","author":"P Tfelt-Hansen","year":"2000","unstructured":"Tfelt-Hansen P, Block G, Dahl\u00f6f C, et al.: International Headache Society Clinical Trials Subcommittee: guidelines for controlled trials of drugs in migraine, edn 2. Cephalalgia 2000, 20:765\u2013786.","journal-title":"Cephalalgia"},{"key":"78_CR2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1468-2982.1995.015003165.x","volume":"15","author":"J Schoenen","year":"1995","unstructured":"Schoenen J: Guidelines for trials of drug treatments in tension-type headache: First Edition. Cephalalgia 1995, 15:165\u2013179.","journal-title":"Cephalalgia"},{"key":"78_CR3","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1517\/14656566.2.10.1649","volume":"2","author":"SD Silberstein","year":"2001","unstructured":"Silberstein SD: Review of botulinum toxin type A and its clinical applications in migraine headache. Expert Opin Pharmacother 2001, 2:1649\u20131654. Comprehensive review of the literature on botulinum toxin in the treatment of migraine.","journal-title":"Expert Opin Pharmacother"},{"key":"78_CR4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/mda.2002.24423","volume":"48","author":"WJ Binder","year":"2002","unstructured":"Binder WJ, Brin MF, Blitzer A, Pogoda JM: Botulinum toxin type A (BOTOX) for treatment of migraine. Dis Mon 2002, 48:323\u2013335.","journal-title":"Dis Mon"},{"key":"78_CR5","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s11916-002-0054-1","volume":"6","author":"A Mauskop","year":"2002","unstructured":"Mauskop A: The use of botulinum toxin in the treatment of headaches. Curr Pain Headache Rep 2002, 6:320\u2013323.","journal-title":"Curr Pain Headache Rep"},{"key":"78_CR6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1046\/j.1468-2982.2002.00390.x","volume":"22","author":"S Evers","year":"2002","unstructured":"Evers S, Rahmann A, Vollmer-Haase J, Husstedt IW: Treatment of headache with botulinum toxin A: a review according to evidence-based medicine criteria. Cephalalgia 2002, 22:699\u2013710. A complete review on all of the studies and case reports focusing on the treatment of different headache disorders with botulinum toxin. The studies and reports are categorized according to evidence-based medicine criteria.","journal-title":"Cephalalgia"},{"issue":"suppl 1","key":"78_CR7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/PL00007818","volume":"248","author":"H G\u00f6bel","year":"2001","unstructured":"G\u00f6bel H, Heinze A, Heinze-Kuhn K, Jost WH: Evidence-based medicine: botulinum toxin A in migraine and tension-type headache. J Neurol 2001, 248(suppl 1):34\u201338.","journal-title":"J Neurol"},{"key":"78_CR8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11940-002-0047-8","volume":"4","author":"NT Mathew","year":"2002","unstructured":"Mathew NT, Kaup AO: The use of botulinum toxin type A in headache treatment. Curr Treat Options Neurol 2002, 4:365\u2013373. A review on all of the studies, reports, and congress contributions dealing with headache and botulinum toxin. Short, but precise description of the literature.","journal-title":"Curr Treat Options Neurol"},{"issue":"suppl 7","key":"78_CR9","first-page":"1","volume":"8","author":"Headache Classification Committee of the International Headache Society","year":"1988","unstructured":"Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia 1988, 8(suppl 7):1\u201392.","journal-title":"Cephalalgia"},{"issue":"suppl 2","key":"78_CR10","first-page":"158","volume":"9","author":"J Krusz","year":"2002","unstructured":"Krusz J: Intradermal Botulinum toxin, type A, treatment for cervicogenic migraine. Eur J Neurol 2002, 9(suppl 2):158.","journal-title":"Eur J Neurol"},{"issue":"suppl 2","key":"78_CR11","first-page":"188","volume":"9","author":"J Krusz","year":"2002","unstructured":"Krusz J: Intradermal botulinum toxin, type B, treatment for cervicogenic migraine. Eur J Neurol 2002, 9(suppl 2):188.","journal-title":"Eur J Neurol"},{"key":"78_CR12","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/ajhp\/59.19.1860","volume":"59","author":"MO Fadeyi","year":"2002","unstructured":"Fadeyi MO, Adams QM: Use of botulinum toxin type B for migraine and tension headaches. Am J Health Syst Pharm 2002, 59:1860\u20131862.","journal-title":"Am J Health Syst Pharm"},{"key":"78_CR13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1526-4610.2000.00066.x","volume":"40","author":"S Silberstein","year":"2000","unstructured":"Silberstein S, Mathew N, Saper J, Jenkins S: Botulinum toxin type A as a migraine preventive treatment. Headache 2000, 40:445\u2013450. The only fully published randomized, placebo-controlled, and double-blind study on botulinum toxin in the prophylaxis of migraine. Significant efficacy was found only for the low dose of botulinum toxin A, not for the high dose.","journal-title":"Headache"},{"key":"78_CR14","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1468-2982.2000.020004421.x","volume":"20","author":"MF Brin","year":"2000","unstructured":"Brin MF, Swope DM, O\u2019Brian C, et al.: Botox, for migraine: double-blind, placebo-controlled, region-specific evaluation. Cephalalgia 2000, 20:421\u2013422.","journal-title":"Cephalalgia"},{"key":"78_CR15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1067\/mhn.2000.110960","volume":"123","author":"WJ Binder","year":"2000","unstructured":"Binder WJ, Brin MF, Blitzer A, et al.: Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an openlabel study. Otolaryngol Head Neck Surg 2000, 123:669\u2013676.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"78_CR16","first-page":"422","volume":"20","author":"A Mauskop","year":"2000","unstructured":"Mauskop A, Basdeo R: Botulinum toxin A is an effective prophylactic therapy for migraines. Cephalalgia 2000, 20:422.","journal-title":"Cephalalgia"},{"key":"78_CR17","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1046\/j.1468-2982.2000.020004332.x","volume":"20","author":"JA Smuts","year":"2000","unstructured":"Smuts JA, Barnard PWA: Botulinum toxin type A in the treatment of headache syndromes: a clinical report on 79 patients. Cephalalgia 2000, 20:332\u2013337.","journal-title":"Cephalalgia"},{"key":"78_CR18","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/00006534-200206000-00001","volume":"109","author":"B Guyuron","year":"2002","unstructured":"Guyuron B, Tucker T, Davis J: Surgical treatment of migraine headaches. Plast Reconstr Surg 2002, 109:2183\u20132189.","journal-title":"Plast Reconstr Surg"},{"issue":"suppl 3","key":"78_CR19","first-page":"A349","volume":"56","author":"L Robbins","year":"2001","unstructured":"Robbins L: Botulinum toxin A for refractory chronic daily headache. Neurology 2001, 56(suppl 3):A349.","journal-title":"Neurology"},{"key":"78_CR20","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1046\/j.1526-4610.1998.3806468.x","volume":"38","author":"AH Wheeler","year":"1998","unstructured":"Wheeler AH: Botulinum toxin A, adjunctive therapy for refractory headaches associated with pericranial muscle tension. Headache 1998, 38:468\u2013471.","journal-title":"Headache"},{"key":"78_CR21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1468-2982.2000.00079.x","volume":"20","author":"JA Klapper","year":"2000","unstructured":"Klapper JA, Mathew NT, Klapper A, Kailasam J: Botulinum toxin type A (BTX-A) for the prophylaxis of chronic daily headache. Cephalalgia 2000, 20:291\u2013292.","journal-title":"Cephalalgia"},{"key":"78_CR22","first-page":"1199","volume":"84","author":"N Poungvarin","year":"2001","unstructured":"Poungvarin N: The first world report of botulinum A toxin injection for status migrainosus. J Med Assoc Thai 2001, 84:1199\u20131203.","journal-title":"J Med Assoc Thai"},{"key":"78_CR23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11916-999-0069-y","volume":"3","author":"BM Guyer","year":"1999","unstructured":"Guyer BM: Mechanism of botulinum toxin in the relief of chronic pain. Curr Rev Pain 1999, 3:427\u2013431.","journal-title":"Curr Rev Pain"},{"key":"78_CR24","first-page":"151","volume":"20","author":"AO Ceballos-Baumann","year":"2001","unstructured":"Ceballos-Baumann AO, Petri S, Toelle T, et al.: Neues in der Botulinum toxin-Therapie: Von der Dystonie bis zur Migr\u00e4neprophylaxe. Nervenheilkunde 2001, 20:151\u2013157.","journal-title":"Nervenheilkunde"},{"key":"78_CR25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/mds.870100317","volume":"10","author":"C Pacchetti","year":"1995","unstructured":"Pacchetti C, Albani G, Martignoni E, et al.: \u201cOff\u201d painful dystonia in Parkinson\u2019s disease treated with botulinum toxin. Mov Disord 1995, 10:333\u2013336.","journal-title":"Mov Disord"},{"key":"78_CR26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0885-3924(00)00146-9","volume":"20","author":"J Wissel","year":"2000","unstructured":"Wissel J, M\u00fcller J, Dressnandt J, et al.: Management of spasticity associated pain with botulinum toxin A. J Pain Symptom Manage 2000, 20:44\u201349.","journal-title":"J Pain Symptom Manage"},{"key":"78_CR27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1017\/S0012162200000220","volume":"42","author":"S Barwood","year":"2000","unstructured":"Barwood S, Baillieu C, Boyd R, et al.: Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial. Dev Med Child Neurol 2000, 42:116\u2013121.","journal-title":"Dev Med Child Neurol"},{"key":"78_CR28","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3109\/00016489309135834","volume":"113","author":"GM Filippi","year":"1993","unstructured":"Filippi GM, Errico P, Santarelli R, et al.: Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolaryngol 1993, 113:400\u2013404.","journal-title":"Acta Otolaryngol"},{"key":"78_CR29","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<488::AID-MUS9>3.0.CO;2-8","volume":"19","author":"RL Rosales","year":"1996","unstructured":"Rosales RL, Arimura K, Ikenaga S, Osame M: Extrafusal and intrafusal muscle effects in experimental botulinum toxin A injection. Muscle Nerve 1996, 19:488\u2013496.","journal-title":"Muscle Nerve"},{"key":"78_CR30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0022-510X(02)00313-1","volume":"205","author":"W Blersch","year":"2002","unstructured":"Blersch W, Schulte-Mattler WJ, Przywara S, et al.: Botulinum toxin A and the cutaneous nociception in humans: a prospective, double-blind, placebo-controlled, randomized study. J Neurol Sci 2002, 205:59\u201363. An interesting and well-designed study showing that botulinum toxin A does not influence the cutaneous nociception in a human pain model.","journal-title":"J Neurol Sci"},{"key":"78_CR31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00500893","volume":"298","author":"H Wiegand","year":"1977","unstructured":"Wiegand H, Erdmann G, Wellh\u00f6ner HH: 125I-labelled botulinum A neurotoxin: pharmacokinetics on cats after intramuscular injection. Naunyn Schmiedebergs Arch Pharmacol 1977, 298:235\u2013238.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"78_CR32","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1046\/j.1471-4159.1999.0730372.x","volume":"73","author":"C Verderio","year":"1999","unstructured":"Verderio C, Coco S, Rossetto O, et al.: Internalization and proteolytic action of botulinum toxins in CNS neurons and astrocytes. J Neurochem 1999, 73:372\u2013379.","journal-title":"J Neurochem"},{"key":"78_CR33","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0041-0101(99)00153-1","volume":"38","author":"MJ Welch","year":"2000","unstructured":"Welch MJ, Purkiss JR, Foster KA: Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins. Toxicon 2000, 38:245\u2013258.","journal-title":"Toxicon"},{"key":"78_CR34","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ana.410330109","volume":"33","author":"PJ Goadsby","year":"1993","unstructured":"Goadsby PJ, Edvinsson L: The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993, 33:48\u201356.","journal-title":"Ann Neurol"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-003-0078-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11916-003-0078-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-003-0078-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:34:10Z","timestamp":1559435650000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11916-003-0078-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["78"],"URL":"https:\/\/doi.org\/10.1007\/s11916-003-0078-1","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5]]}}}